Iktos enters into AI agreement with Merck KGaA, Darmstadt, Germany
Category: #business |   By Pankaj Singh |   Date: 2020-11-07

Iktos enters into AI agreement with Merck KGaA, Darmstadt, Germany

AI-specialized new drug design major, Iktos, has reportedly entered into an additional partnership agreement in artificial intelligence for new drug design with leading science and technology firm, Merck KGaA, Darmstadt, Germany. This agreement focuses on the utilization of Iktos’ novel generative design technology in a structure-enabled context for facilitating the cost-effective and rapid design of an unannounced Merck KGaA, Darmstadt, Germany drug discovery initiative.

As per the Global Head of Research for the Healthcare business, Merck KGaA, Darmstadt, Germany, Joern-Peter Halle, AI possesses the potential for the acceleration and improvement of drug discovery process, implying faster access to novel treatment alternatives for patients. This additional partnership is a demonstration of the company’s commitment to collaborations for the purpose of accessing the latest technology to enrich the company’s discovery engine, added Halle.

In the past three years, Iktos has successfully emerged as a global leader in artificial intelligence for drug design. The company was reportedly the first AI major to publish an experimental certification of the generative artificial intelligence technology for MPO in a real-life drug discovery project in 2018, since which the firm has entered into agreements with biopharmaceutical companies.

As per sources, Iktos markets its AI technology both as software products and as services. The company’s Makya, generative AI SaaS software, has already been delivered to numerous customers, and its retro-synthesis AI SaaS platform, Spaya, is presently being deployed as a custom version with the firm’s IT infrastructure.

Iktos’ AI technology, helps in bringing efficiency and speed to the drug discovery process, via automatic designing of virtual novel molecules having desired activities for the treatment of a given disease. This is speculated to address one of the prominent issues in drug design, pertaining to the quick identification of molecules that simultaneously meet various drug-like and bioactivity criteria related to drug development and discovery.

 

Source Credits:

https://www.businesswire.com/news/home/20201105005068/en/Iktos-Announces-Additional-Collaboration-With-Merck-KGaA-Darmstadt-Germany-in-AI-for-New-Drug-Design

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh     Twitter

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with Read more...

More News By Pankaj Singh

U.K.’s economy to slump worse than other countries in 2023, says IMF

U.K.’s economy to slump worse than other countries in 2023, says IMF

By Pankaj Singh

The U.K. economy is reportedly set to decline and perform worse as compared to other major nations, notably Russia, as the cost of living remains high, as per the International Monetary Fund (IMF). According to the IMF, the economic output would d...

Oil prices hike as China curbs travel rules and US fights winter storm

Oil prices hike as China curbs travel rules and US fights winter storm

By Pankaj Singh

Oil prices reportedly surged to record a three-week high as China lifted its zero-covid policy and extremely cold weather in the United States forced refinery closures along the critical Texas Gulf Coast. Brent crude rose 88 US cents, or 1.1%, to ...

EU accepts carbon market access for $21.3 billion in the energy shift

EU accepts carbon market access for $21.3 billion in the energy shift

By Pankaj Singh

The European Union (EU) policymakers have reportedly agreed to raise nearly $21.3 billion (€20 billion) from the carbon market of that region, to support financing the bloc's strategy to alleviate its reliance on Russia for natural gas in a ...